Russian SARS2 Vaccine safe, 92% effective for even 60s plus

“The efficacy looks good, including in the over 60s,” said Danny Altmann, a professor of immunology at Imperial College London. “It’s good to have another addition to the global arsenal.”

2,144 Volunteers over 60 in the Sputnik V trial proved the vaccine to be 91.8% effective. There were no serious side-effects reported that could be associated with the vaccine a detailed peer-reviewed report in The Lancet said.

The Sputnik V vaccine can be stored in refrigerators and thus easily distributed and it will require two distinctly different doses, twenty-one days apart.

by Melissa Hemingway


Safe and effective Russian Vaccine added to teh stable of good vaccines “What then of the Sputnik V COVID-19 vaccine data published in the Lancet? The earlier phase 1/2 data published in September, 2020, showed promising safety results and gave an indication that the immune response was at a level consistent with protection.
Recipients generated robust antibody responses to the spike protein, which included neutralizing antibodies, the proportion of the total immunoglobulin that inhibits the virus binding to its receptor. They also showed evidence of T-cell responses, consistent with an immune response that should not quickly wane.” Reports the highly respected global medical journal, The Lancet. Photo Credit: Melissa Hemingway. 

“The Sputnik V vaccine uses a heterologous recombinant adenovirus approach using adenovirus 26 (Ad26) and adenovirus 5 (Ad5) as vectors for the expression of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein. The use of two varying serotypes, which are given 21 days apart, is intended to overcome any pre-existing adenovirus immunity in the population,” notes the Lancet.

Read detailed medical evaluation of the Phase III trials from “Sputnik V COVID-19 vaccine candidate appears safe and effective.”

Russian citizens have already been offered the vaccine since the start of the year.  Frontline workers in Russia were given the vaccine last year.

Current Global COVID-19 Statistics (19 Apr 2024)